Dr. Sanket Mehta is a Consultant Oncologist, HIPEC and a Robotic Surgeon
about me

Dr. Sanket Mehta

Dr. Sanket Mehta is currently affiliated with Saifee Hospital and Sir H N Reliance Foundation Hospital, Mumbai.

He has also trained in the treatment of advanced and metastatic malignancies of colorectal, ovarian and peritoneal origin and in hepato-pancreato- biliary surgery in Val d' Aurelle institute, France and in Medstar Washington Memorial Hospital, Washington DC.

He is the Chief of Division of Peritoneal Surface Oncology at Saifee Hospital which was the first dedicated Peritoneal surface malignancy unit established in country. He has started the first HIPEC clinic, a Centre dedicated for treatment and care of patients undergoing CRS & HIPEC. It has a team of professionals providing excellent services including pre and post HIPEC counseling, stoma care therapists , dietary and nutritional guidance for patients undergoing major cancer surgery.

expert

area of specialization

Dr. Sanket Mehta's area of specialization includes HIPEC, CRS, GI malignancies, laproscopic and robotic surgery

Pioneer in CRS and HIPEC in India

Specialises in treatment of GI and Gynacaelogic malignancies

Treatment of early cancers - laparoscopic and robotic surgery

Complex Recurrent cancers - Different malignancies

Treatment of RetroPeritoneal sarcomas

qualifications

Academic qualifcations and fellowships awarded to Dr. Sanket Mehta
Graduation

LTMGH Sion

Specialisation in Oncosurgery

Tata Memorial Hospital

Fellowships

Fellowship GI oncology department. oncology and Cytoreductive surgery (CRLC Val d’Aurelle, France)

Fellowship in Minimal Access and Gastro-intestinal surgery (L’Hopital Saint Eloi, Centre Hospitaliere Universitaire, Montpellier)

Fellowship in Laparoscopic and Robotic colorectal surgery (St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea)

experience

Tata Memorial Hopital.

Rich experience in minimal invasive, robotic surgery and cytoreducetive surgery and hip over a span of 2 years in Korea and France.

Established 1st peritoneal surface oncology department in the country at Saifee hospital which has been treating 100s of patients every year from across the country since 2011.

One of the largest experience in minimal invasive and robotic surgery in Mumbai city.

Attended and participated in the International symposium on Laparoscopic colorectal surgery in 2009 at Deagu, South Korea.

"Attended the daVinci Live 2009 workshop on Robotic surgery in Seoul, South Korea Participated in the 7th International Bi-annual workshop on peritoneal surface malignancy in 2010, Uppsala, Sweden Participated in the 8th Bi-annual pertitoneal surface malignacy workshop in 2012, Berlin. Trained with Dr. Sugarbaker at Medstar Washington Memorial Hospital for treatment of rare peritoneal diseases"

GLory

Awards and Achievements

  • Rotary International Ambassadorial Scholarship awarded to Dr. Sanket Mehta

    Recipient of the prestigious Rotary International Ambassadorial Scholarship for the year 2009-2010

  • First Indian Surgeon to present at the ASCO-GI meet

    First Indian surgeon to make a presentation in ASCO-GI meet on Cytoreductive surgery and HIPEC for colorectal carcinomatosis

  • Rotary International Ambassadorial Scholarship awarded to Dr. Sanket Mehta

    First surgeon to perform Cytoreductive surgery and HIPEC using the advanced HIPEC system in the country

  • First Indian Surgeon to present at the ASCO-GI meet

    Recipient of the prestigious Rotary International Ambassadorial Scholarship for the year 2009-2010

  • First Indian Surgeon to present at the ASCO-GI meet

    First Surgeon in the country to perform TEO surgeries including Trans-anal full-thickness resection of benign tumors, villous adenomas, large polyps and Transanal Total Mesorectal Excision (TATME).

indepth knowledge

research and publications

Joshi RM, Palep JH, Sayed S, Mehta S. Hepatic resection: An insight. Indian J Surg 2005;67:13-20

Mistry RC, Mehta SS, Karimundackal G, Pramesh CS. Novel cost-effective method of laparoscopic feeding-jejunostomy. J Minim Access Surg 2009;5(2):43-6

Vijayabhaskar R, Mehta SS, Deodhar KK, Pramesh CS, Mistry RC. PEComa of the lung. J Cancer Res Ther. 2010 Jan-Mar;6(1):109-11

Quenet F, Goere D, Mehta SS, Roca L, Mehdi H, Saint-Aubert B, Elias D. Results of two bi- institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC following cytoreductive surgery for colorectal carcinomatosis. Annals of Surgery. 254(2):294-301, August 2011

Mehta SS, Doumaine G, Mura T, Nocca D, Fabre JM. Laparoscopic versus open distal pancreatectomy – A mono-institutional case-control study. Surg Endosc Volume 26, Issue 2(2012), Page 402-407

F. Quenet, C. Escaloya, A Viot, S Mehta, J J Torrent. Peritoneal Carcinomatosis of Colorectal Origin. Eur J Cancer, Sept 2011.

F. Quenet, D. Goere, S. Mehta. Chimiohyperthermie intra péritonéale par Oxaliplatine ® ou Oxali-irinotecan® après cytoréduction complete de la carcinose péritonéale d’origine cool-rectale. Etude prospective bicentrique a propos de 146 patients.

F. Quenet, S Mehta. HIPEC: Yes or no? Eur J Surg oncol, Sept 2012.

Bhatt A, Mehta SS, Seshadri R, et al. The initial Indian Experience with Cytoreductive surgery and HIPEC in the Treatment of Peritoneal Metastases. Indian J Surg Oncol, Feb 2016.

Mehta SS, Gelli M, Agarwal D, Goere D. Complications of Cytoreductive Surgery and HIPEC in the treatment if Peritoneal Metastases. Indian J Surg Oncol, Feb 2016.

Mehta SS, Bhatt A, Glehen O. Cytoreductive surgery and Peritonectomy procedures. Indian J Surg Oncol, Feb 2016.

indepth knowledge

presentation

Oral Communication, 6ème Congrès Francophone de Chirurgie Digestive et Hépato-Biliaire, December 2010. Chimiohyperthermie intra péritonéale par oxaliplatine ou oxali-irinotecan après cytoréduction complète de la carcinose péritonéale d’origine colo-rectale. Etude prospective bicentrique à propos de 146 patients

Oral Communication, ESSO 2010 – 15th Congress of the European Society of Surgical Oncology, Bordeaux. Carcinologic Resection of Abdominal Tumors Involving Retroperitoneal Vessels: Results of a Synergical Multidisciplinary Approach between Oncological and Vascular Surgical Teams

Oral Communication, 6ème Congrès Francophone de Chirurgie Digestive et Hépato- Biliaire, December 2010. Chimiohyperthermie intra péritonéale par oxaliplatine ou oxali- irinotecan après cytoréduction complète de la carcinose péritonéale d’origine colo-rectale. Etude prospective bicentrique à propos de 146 patients.

Oral Communication, ESSO 2010 – 15th Congress of the European Society of Surgical Oncology, Bordeaux. Carcinologic Resection of Abdominal Tumors Involving Retroperitoneal Vessels: Results of a Synergical Multidisciplinary Approach between Oncological and Vascular Surgical Teams.

Poster presentation and communication, ASCO 2011, San Francisco, Gastrointestinal Cancers Symposium - Category: Cancers of the Colon and Rectum - Multidisciplinary Treatment - Two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC following complete cytoreductive surgery for colorectal carcinomatosis.

Poster presentation, EHPBA 2005- Heidelburg “Complications following Pancreato-biliary surgery- An Audit”.

Several paper and poster presentations in National level conferences including MASICON, ICON, NATCON, IAHCON, AGOICON etc. on CRS+HIPEC and Laparoscopic oncosurgery.

influence

Hospital Affiliations

Consultation

Affiliation

  • Saifee Hospital

    15/17, Maharshi Karve Marg,
    Mumbai - 400 004,
    Maharashtra. Location icon

  • Sir H. N. Reliance Foundation Hospital and Research Centre

    Raja Rammohan Roy Road,
    Prarthana Samaj, Girgaon,
    Mumbai - 400004.Location icon

  • Breach Candy Hospital

    60 A, Bhulabhai
    Desai Road, Mumbai,
    Maharashtra 400026Location icon

  • Jaslok Hospital

    15, Dr. Deshmukh Marg,
    Peddar Road, Mumbai, 400026
    Maharashtra. Location icon